Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-132085
Filing Date
2026-03-30
Accepted
2026-03-30 17:39:27
Documents
97
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lxeo-20251231.htm   iXBRL 10-K 3881416
2 EX-10.14 lxeo-ex10_14.htm EX-10.14 95536
3 EX-10.20 lxeo-ex10_20.htm EX-10.20 39741
4 EX-10.23 lxeo-ex10_23.htm EX-10.23 244242
5 EX-10.41 lxeo-ex10_41.htm EX-10.41 30129
6 EX-10.42 lxeo-ex10_42.htm EX-10.42 95301
7 EX-23.1 lxeo-ex23_1.htm EX-23.1 16692
8 EX-31.1 lxeo-ex31_1.htm EX-31.1 15942
9 EX-31.2 lxeo-ex31_2.htm EX-31.2 15946
10 EX-32.1 lxeo-ex32_1.htm EX-32.1 8159
11 EX-32.2 lxeo-ex32_2.htm EX-32.2 8262
12 GRAPHIC img47974566_0.jpg GRAPHIC 13721
13 GRAPHIC img47974566_1.jpg GRAPHIC 15033
14 GRAPHIC img147150826_0.jpg GRAPHIC 106272
15 GRAPHIC img147150826_1.jpg GRAPHIC 125267
16 GRAPHIC img147150826_2.jpg GRAPHIC 141481
17 GRAPHIC img147150826_3.jpg GRAPHIC 230055
18 GRAPHIC img147150826_4.jpg GRAPHIC 176325
19 GRAPHIC img147150826_5.jpg GRAPHIC 108703
20 GRAPHIC img147150826_6.jpg GRAPHIC 166415
21 GRAPHIC img147150826_7.jpg GRAPHIC 340394
22 GRAPHIC img147150826_8.jpg GRAPHIC 122759
23 GRAPHIC img147150826_9.jpg GRAPHIC 4484
24 GRAPHIC img147150826_10.jpg GRAPHIC 3502
25 GRAPHIC img238985936_0.jpg GRAPHIC 29647
  Complete submission text file 0001193125-26-132085.txt   18365497

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lxeo-20251231.xsd EX-101.SCH 1911475
101 EXTRACTED XBRL INSTANCE DOCUMENT lxeo-20251231_htm.xml XML 2220731
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41855 | Film No.: 26813842
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)